evekhm/cms_iom_500 huggingface dataset:
(Change Management Web Portal - CR Detail)
When the services are no t subject to QIO Review, the in termediary or carrier is responsible for determ ining that satisfactory m edical justification exis ts.  This includes:   Amylase, blood isoenzym es, electrophoretic,  Chro mium, blood,  Guanase, blood,  Zinc sulphate turbidity, blood,  Skin test, ca t scra tch fever,  Skin test, lymphopathia venereum ,  Circulation tim e, one test,  Cephalin f loccula tion,  Congo red, blood,  Hormones, adrenocorticotropin quantita tive an imal te sts,  Hormones, adrenocorticotropin quantitative bioassay,  Thymol turbidity, blood,   Skin test, ac tinom ycosis,  Skin test, br ucello sis,  Skin test, ps ittacosis,  Skin test, tr ichinosis,  Calcium , feces, 24-hour quantitative,   Starch, feces , screen ing,  Chymotrypsin, duodenal contents,  Gastric analysis, peps in,  Gastric analysis, tubeles s,  Calcium  saturation clo tting tim e,  Capilla ry fragility te st (R umpel-Leed e),   Colloida l gold,  Bendiens test for cancer and tubercu losis,  Bolens test for cancer,  Rehfuss test for gastric acidity, and  Serum  seromucoid assay for cancer and other d iseases.  B.   Cardiovascular Tests   Do not pay for the following phonocardiograph y and vectorcardiography diagnostic tests because they have been determ ined to be out moded and of little clinical value.  They include :
(Change Management Web Portal - CR Detail)
B.   Cardiovascular Tests   Do not pay for the following phonocardiograph y and vectorcardiography diagnostic tests because they have been determ ined to be out moded and of little clinical value.  They include :   Phonocardiogram  with or without E CG lead; with supervision during recording with interpretation and report (when e quipm ent is supplied by the physician),  Phonocardiogram ; tracing only, without interpretation and report (e.g., w hen equipm ent is supplied b y the hospita l, clinic ),  Phonocardiogram ; interpretation and report,  Phonocardiogram  with ECG lead, with indir ect carotid artery and/or jugular vein tracing, and/or apex cardiogram ; with inte rpretation and repo rt,  Phonocardiogram ; without interpretation and report,  Phonocardiogram ; interpre tation and report only,   Intracard iac,  Vectorcardiogram  (VCG), w ith or without ECG; with interpretation and report,  Vectorcardiogram ; tracing only, without interpretation and report, and  Vectorcardiogram ; interp retation and report only.
(Medicare National Coverage Determinations Manual)
Medicare National Coverage Determinations Manual Crosswalk CIM to NCD Sections The column on the far right (column 3) is in CIM sequence. Column 1 shows the NDC Manual section.  Note that the sections in the NCD are in CPT category sequence and not in Medicare benefit category sequence.  NCD Section Title CIM Section  310.1 Routine Costs in Clinical Trails CIM 30-1 10.8.1 Stem Cell Transplantation CIM 35.30.1 100.7 Colonic Irrigation CIM 35-1 20.29 Hyperbaric Oxygen Therapy CIM 35-10 80.2 Photodynamic Therapy CIM 35-100 250.4 Treatment of Actinic Keratosis CIM 35-101 160.25 Multiple Electroconvulsive Therapy (MECT) CIM 35-103 260.5 Intestinal and Multivisceral Transplantation CIM 35-104 230.3 Sterilization CIM 35-11 140.4 Plastic Surgery to Correct "Moon Face" CIM 35-12 150.7 Prolotherapy; Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents CIM 35-13 70.1 Consultations With a Beneficiarys Family and Associates CIM 35-14 240.7 Postural Drainage Procedures and Pulmonary Exercises CIM 35-15 80.11 Vitrectomy CIM 35-16 160.1 Induced Lesions of Nerve Tracts CIM 35-17 30.4 Electrosleep Therapy CIM 35-18 30.6 Intravenous Histamine Therapy CIM 35-19 NCD Section Title CIM Section  150.1 Manipulation CIM 35-2 160.2 Treatment of Motor Function Disorders with Electric Nerve Stimulation CIM 35-20 10.3 Inpatient Hospital Pain Rehabilitation Programs CIM 35-21 10.4 Outpatient Hospital Pain Rehabilitation Programs CIM 35-21.1 130.1 Inpatient Hospital Stays for the Treatment of Alcoholism CIM 35-22 130.2 Outpatient Hospital Services for Treatment of Alcoholism CIM 35-22 130.6 Treatment of Drug Abuse (Chemical Dependency) CIM 35-22.2 130.5 Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic CIM 35-22.3 130.3 Chemical Aversion Therapy for Treatment of Alcoholism CIM 35-23 130.4 Electrical Aversion Therapy for Treatment of Alcoholism CIM
(Medicare National Coverage Determinations Manual)
Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic CIM 35-22.3 130.3 Chemical Aversion Therapy for Treatment of Alcoholism CIM 35-23 130.4 Electrical Aversion Therapy for Treatment of Alcoholism CIM 35-23.1 230.4 Diagnosis and Treatment of Impotence CIM 35-24 20.10 Cardiac Rehabilitation Programs CIM 35-25 40.5 Treatment of Obesity CIM 35-26 30.1 Biofeedback Therapy CIM 35-27 30.1.1 Biofeedback Therapy For The Treatment Of Urinary Incontinence CIM 35-27.1 50.5 Oxygen Treatment of Inner Ear/Carbon Therapy CIM 35-29 240.3 Heat Treatment, Including the Use of Diathermy and Ultra-Sound for Pulmonary Conditions CIM 35-3 110.8 Blood Platelet Transfusions CIM 35-30 NCD Section Title CIM Section  270.4 Treatment Of Decubitus Ulcers CIM 35-31  100.8 Intestinal By-Pass Surgery CIM 35-33 230.2 Uroflowmetric Evaluations CIM 35-33 20.23 Fabric Wrapping of Abdominal Aneurysms CIM 35-34 20.28 Therapeutic Embolization CIM 35-35 20. 01 Vertebral Artery Surgery CIM 35-37 20. 2 Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery CIM 35-37 110.15 Ultrafiltration, Hemoperfusion and Hemofiltration CIM 35-38 80.6 Intraocular Photography CIM 35-39 50.8 Ultrasonic Surgery CIM 35-4 100.1 Gastric Bypass Surgery for Obesity CIM 35-40 150.5 Diathermy Treatment CIM 35-41 130.7 Withdrawal Treatments for Narcotic Addictions CIM 35-42 10.1 Use Of Visual Tests Prior To And General Anesthesia During Cataract Surgery  CIM 35-44 20.25 Cardiac Catheterization Performed in Other Than a Hospital Setting CIM 35-45 160.3 Assessing Patients Suitability for Electrical Nerve Stimulation CIM 35-46 160.7.1 Assessing Patients Suitability for Electrical Nerve Stimulation Therapy CIM 35-46 140.2 Breast Reconstruction Following Mastectomy CIM 35-47 150.2 Osteogenic Stimulator CIM 35-48 160.11
(Medicare National Coverage Determinations Manual)
160.7.1 Assessing Patients Suitability for Electrical Nerve Stimulation Therapy CIM 35-46 140.2 Breast Reconstruction Following Mastectomy CIM 35-47 150.2 Osteogenic Stimulator CIM 35-48 160.11 Osteogenic Stimulation  CIM 35-48 NCD Section Title CIM Section  110.1 Hyperthermia for Treatment of Cancer CIM 35-49 30.8 Cellular Therapy CIM 35-5 50.7 Cochleostomy with Neurovascular Transplant for Menieres Disease CIM 35-50 130.8 Hemodialysis for Treatment of Schizophrenia CIM 35-51 140.5 Laser Procedures CIM 35-52 260.1 Adult Liver Transplantation CIM 35-53 260.2 Pediatric Liver Transplantation CIM 35-53.1 80.7 Refractive Keratoplasty CIM 35-54 240.6 Transvenous (Catheter) Pulmonary Embolectomy CIM 35-55 150.8 Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders CIM 35-56 160.8 Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral Vasculature CIM 35-57 160.9 Electroencephalographic (EEG) Monitoring During Open-Heart Surgery CIM 35-57.1 20.3 Thoracic Duct Drainage (TDD) In Renal Transplants CIM 35-58 100.2 Endoscopy CIM 35-59 30.2 Thermogenic Therapy CIM 35-6 110.14 Apheresis  (Therapeutic Pheresis) CIM 35-60 140.3 Transsexual Surgery CIM 35-61 160.14 Invasive Intracranial Pressure Monitoring CIM 35-62 50.6 Tinnitus Masking CIM 35-63 20.21 Chelation Therapy for Treatment of AtherosclerosisCIM 35-64 NCD Section Title CIM Section  Atherosclerosis 100.6 Gastric Freezing CIM 35-65 250.1 Treatment of Psoriasis CIM 35-66 170.2 Melodic Intonation Therapy CIM 35-67 100.9 Implantation of Anti-Gastroesophageal Reflux Device CIM 35-69 20.18 Carotid Body Resection/Carotid Body Denervation CIM 35-7 40.3 Closed-Loop Blood Glucose Control Device
(Medicare National Coverage Determinations Manual)
of Anti-Gastroesophageal Reflux Device CIM 35-69 20.18 Carotid Body Resection/Carotid Body Denervation CIM 35-7 40.3 Closed-Loop Blood Glucose Control Device (CBGCD) CIM 35-70 110.16 Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation CIM 35-71 160.15 Electrotherapy for Treatment of Facial Nerve Palsy (Bells Palsy) CIM 35-72 100.10 Injection Sclerotherapy for Esophageal Variceal Bleeding   CIM 35-73 20.20 External Counterpulsation (ECP) for Severe Angina CIM 35-74 20.11 Intraoperative Ventricular Mapping  CIM 35-75 150.4 Neuromuscular Electrical Stimulator (NMES) in the Treatment of Disuse Atrophy CIM 35-77 160.12 Neuromuscular Electrical Stimulation (NMES) in the Treatment of Disuse Atrophy CIM 35-77 20.12 Diagnostic Endocardial Electrical Stimulation (Pacing)    CIM 35-78 10.6 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 20.8.3 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 30.3 Acupuncture CIM 35-8 NCD Section Title CIM Section  230.1 Treatment of Kidney Stones CIM 35-81 260.3 Pancreas Transplants CIM 35-82 100.3 24-Hour Ambulatory Esophegeal pH Monitoring CIM 35-83 160.4 Steroetactic Cingulotomy as a Means of Psychosurgery CIM 35-84 20.4 Implantation of Automatic Defibrillators CIM 35-85 100.11 Gastric Balloon for Treatment of Obesity CIM 35-86 260.9 Heart Transplants CIM 35-87 110.4 Extracorporeal Photopheresis CIM 35-88 170.3 Speech Pathology Services for the Treatment of Dysphagia CIM 35-89 80.10 Phaco-Emulsification Procedure  (Cataract Extraction) CIM 35-9 20.5 Extracorporeal Immunoadsorption (ECI) Using Protein A Columns  CIM 35-90
(Medicare National Coverage Determinations Manual)
35-89 80.10 Phaco-Emulsification Procedure  (Cataract Extraction) CIM 35-9 20.5 Extracorporeal Immunoadsorption (ECI) Using Protein A Columns  CIM 35-90 100.13 Laproscopic Cholecystectomy CIM 35-91 30.5 Transcendental Meditation CIM 35-92 240.1 Lung Volume Reduction Surgery (Reduction Pneumoplasty) CIM 35-93 20.6 Transmyocardial Revascularization (TMR) CIM 35-94 20.26 Partial Ventriculectomy CIM 35-95 230.9 Cryosurgery of Prostate CIM 35-96 160.16 Vertebral Axial Decompression (VAX-D) CIM 35-97 270.1 Electrostimulation in the Treatment of Wounds CIM 35-98 140.1 Abortion  CIM 35-99 NCD Section Title CIM Section  160.17 L-Dopa  CIM 45-1 30.7 Laetrile and Related Substances CIM 45-10 10.5 Autogenous Epidural Blood Graft CIM 45-11 270.5 Porcine Skin and Gradient Pressure Dressings CIM 45-12 70.3 Physicians Office Within an Institution  Coverage of Services and Supplies Incident to a Physicians Services CIM 45-15 110.2 Certain Drugs Distributed by the National Cancer Institute CIM 45-16 160.20 Transfer Factor For Treatment of Multiple Sclerosis CIM 45-17 110.5 Granulocyte Transfusions CIM 45-18 10.2 Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain CIM 45-19 20.22 Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis CIM 45-20 110.6 Scalp Hypothermia During Chemotherapy to Prevent Hair Loss CIM 45-21 260.7 Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine) CIM 45-22 230.12 Dimethyl Sulfoxide (DMSO)   CIM 45-23 110.3 Anti-Inhibitor Coagulant Complex (AICC) CIM 45-24 160.13 Supplies Used in the Delivery of
(Medicare National Coverage Determinations Manual)
45-22 230.12 Dimethyl Sulfoxide (DMSO)   CIM 45-23 110.3 Anti-Inhibitor Coagulant Complex (AICC) CIM 45-24 160.13 Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) CIM 45-25 270.3 Platelet-Derived Wound Healing Formula CIM 45-26 110.7 Blood Transfusions CIM 45-27 110.9 Antigens Prepared for Sublingual Administration CIM 45-28 NCD Section Title CIM Section  110.10 Intravenous Iron Therapy CIM 45-29 40.4 Insulin Syringe CIM 45-3 80.3 Photosensitive Drugs CIM 45-30 250.3 Intravenous Immune Globulin For The Treatment Of Autoimmune Mucutaneous Blistering Diseases  CIM 45-31 230.19 Levocarnitine for Use in the Treatment of Carnitine Deficiency in ESRD Patients CIM 45-32 150.6 Vitamin B12 Injections to Strengthen Tendons; Ligaments; etc; of the Foot CIM 45-4 80.1 Hydrophilic Contact Lens for Corneal Bandage CIM 45-7 70.2.1 Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy) CIM 50.8.1 20.8.1 Cardiac Pacemaker Evaluation Services CIM 50-1 20.8.1.1 Transtelephonic Monitoring of Cardiac Pacemakers CIM 50-1 230.6 Vabra Aspirator CIM 50-10 220.1 Computerized Tomography  CIM 50-12 220.2 Magnetic Resonance Imaging CIM 50-13  220.3 Magnetic Resonance Angiography CIM 50-14 20.15 Electrocardiographic Services CIM 50-15 250.2 Hemorheograph CIM 50-16 190.4 Electron Microscope CIM 50-18 70.4 Pronouncement of Death CIM 50-19 110.13 Cytotoxic Food Tests CIM 50-2 NCD Section Title CIM Section  190.2 Diagnostic Pap Smears CIM 50-20 230.11 Diagnostic Pap Smears CIM 50-20 210.2 Screening Pap Smears and Pelvic
(Medicare National Coverage Determinations Manual)
CIM 50-2 NCD Section Title CIM Section  190.2 Diagnostic Pap Smears CIM 50-20 230.11 Diagnostic Pap Smears CIM 50-20 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cance CIM 50-20.1 220.4 Mammograms CIM 50-21 110.12 Challenge Ingestion Food Testing CIM 50-22 190.1 Histocompatibility Testing CIM 50-23 190.6 Hair Analysis CIM 50-24 100.4 Esophageal Manometry CIM 50-25 260.6 Dental Examination Prior to Kidney Transplantation CIM 50-26 220.7 Xenon Scan CIM 50-27 70.5 Hospital and Skilled Nursing Facility Admission Diagnostic Procedures CIM 50-28 190.3 Cytogenetic Studies CIM 50-29 20.13 HIS Bundle Study CIM 50-3 220.8 Nuclear Radiology Procedure CIM 50-30 160.10 Evoked Response Tests CIM 50-31 20.7 Percutaneous Transluminal Angioplasty (PTA)    CIM 50-32 300.1 Obsolete or Unreliable Diagnostic Tests CIM 50-34 190.5 Sweat Test CIM 50-35 220.6 Positron Emission Tomography (PET) Scans CIM 50-36 20.17 Noninvasive Tests of Carotid Function CIM 50-37 80.8 Endothelial Cell Photography   CIM 50-38 160.21 Telephone Transmission of EEGs CIM 50-39 NCD Section Title CIM Section  160.22 Ambulatory EEG Monitoring CIM 50-39.1 230.5 Gravlee Jet Washer CIM 50-4 160.5 Sterotaxic Depth Electrode Implantation CIM 50-40 190.7 Human Tumor Stem Cell Drug Sensitivity Assays CIM 50-41 20.19 Ambulatory Blood Pressure Monitoring CIM 50-42 220.9 Digital Subtraction Angiography CIM 50-43 150.3 Bone (Mineral) Density Studies CIM 50-44 190.8 Lymphocyte Mitogen Response Assays CIM 50-45 30.9 Transillumination Light Scanning or Diaphanography CIM 50-46 20.27 Cardiointegram (CIG) as an Alternative to Stress Test
(Medicare National Coverage Determinations Manual)
Mitogen Response Assays CIM 50-45 30.9 Transillumination Light Scanning or Diaphanography CIM 50-46 20.27 Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test    CIM 50-47 220.10 Portable Hand-Held X-Ray Instrument CIM 50-48 80.9 Computer Enhanced Perimetry CIM 50-49 220.11 Thermography CIM 50-5 20.24 Displacement Cardiography CIM 50-50 100.5 Diagnostic Breath Analyses CIM 50-51 190.9 Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS)  CIM 50-52 110.11 Food Allergy Testing and Treatment CIM 50-53 20.16 Cardiac Output Monitoring By Electrical Bioimpedance CIM 50-54 210.1 Prostate Cancer Screening Tests CIM 50-55 190.11   Home Prothrombin Time INR Monitoring for Anticoagulation Management CIM 50-56 NCD Section Title CIM Section  160.23 Current Perception Threshold/Sensory Nerve Conduction Threshold Test (sNCT) CIM 50-57.1 220.12 Single Photon Emission Computed Tomograph  (SPECT) CIM 50-58 220.13 Percutaneous Image-Guided Breast Biopsy CIM 50-59 20.14 Plethysmography CIM 50-6 220.5 Ultrasound Diagnostic Procedures CIM 50-7 70.2 Consultation Services Rendered By a Podiatrist in a Skilled Nursing Facility CIM 50-8 100.12 Gastrophotography CIM 50-9 230.7 Water Purification and Softening Systems Used in Conjunction with Home Dialysis CIM 55-1 230.13 Peridex CAPD Filter Set CIM 55-2 230.14 Ultrafiltration Monitor   CIM 55-3 40.2 Home Blood Glucose Monitors CIM 60-11 and CIM 60-14
(Medicare National Coverage Determinations Manual)
280.14 Infusion Pumps CIM 60-14 280.5 Safety Roller CIM 60-15 280.6 Pneumatic Compression Devices CIM 60-16 240.4 Continuous Positive Airway Pressure (CPAP) CIM 60-17 280.7 Hospital Beds CIM 60-18 280.8 Air-Fluidized Bed CIM 60-19 280.13 Transcutaneous Electrical Nerve Stimulators (TENS) CIM 60-20 240.5 Intrapulmonary Percussive Ventilator (IPV) CIM 60-21 NCD Section Title CIM Section  160.18 Vagus Nerve Stimulation for Treatment of Seizures CIM 60-22 50.1 Speech Generating Devices CIM 60-23 230.8 Non-Implantable Pelvic Flood Electrical Stimulator CIM 60-24 270.2 Noncontact Normothermic Wound Therapy (NNWT) CIM 60-25 280.2 White Cane for Use by a Blind Person CIM 60-3 240.2 Home Use of Oxygen CIM 60-4 280.9 Power Operated Vehicles That May Be Used as Wheelchairs CIM 60-5 280.3 Specially Sized Wheelchairs CIM 60-6 20.8.2 Self-Contained Pacemaker Monitors CIM 60-7 280.4 Seat Lift CIM 60-8 280.1 Durable Medical Equipment Reference List CIM 60-9 80.5 Scleral Shell CIM 65.3 80.4 Hydrophilic Contact Lenses CIM 65-1 180.2 Enteral and Parenteral Nutritional Therapy CIM 65-10 230.16 Bladder Stimulators (Pacemakers) CIM 65-11 160.19 Phrenic Nerve Stimulator CIM 65-13 50.3 Cochlear Implantation CIM 65-14 20.9 Artificial Hearts and Related Devices CIM 65-16 50.4 Tracheostomy Speaking Valve CIM 65-165 230.17 Urinary Drainage Bags CIM 65-17 230.18 Sacral Nerve Stimulation for Urinary IncontinenceCIM 65-18 NCD Section Title CIM Section  Incontinence 160.24 Deep Brain Stimulation for Essential Tremor and Parkinsons Disease CIM 65-19 230.15 Electrical Continence Aid CIM 65-2 160.6 Carotid Sinus Nerve Stimulator CIM 65-4 50.2
(Medicare National Coverage Determinations Manual)
Deep Brain Stimulation for Essential Tremor and Parkinsons Disease CIM 65-19 230.15 Electrical Continence Aid CIM 65-2 160.6 Carotid Sinus Nerve Stimulator CIM 65-4 50.2 Electronic Speech Aids CIM 65-5 20.8 Cardiac Pacemakers CIM 65-6 80.12 Intraocular Lenses (IOLs) CIM 65-7 160.7 Electrical Nerve Stimulators CIM 65-8 230.10 Incontinence Control Devices CIM 65-9 280.11 Corset Used as Hernia Support CIM 70-1 280.12 Sykes Hernia Control CIM 70-2 280.10 Prosthetic Shoe CIM 70-3 170.1 Institutional and Home Care Patient Education Programs  CIM 80-1 40.1 Diabetes Outpatient Self-Management Training CIM 80-2 180.1 Medical Nutrition Therapy CIM 80-3 290.1 Home Health Visits to a Blind Diabetic CIM 90-1 290.2 Home Health Nurses' Visits to Patients Requiring Heparin Injections CIM 90-2
(Medicare National Coverage Determinations Manual)
Medicare National Coverage Determinations Manual Crosswalk to CIM Sections Cross references are provided at detailed level only (e.g., at each of sections 10.1 through 10.5) as opposed to Section 10. Note that the sections are in CPT category sequence and not in Medicare benefit category sequence. NCD Section Title CIM Section # 10 Anesthesia and Pain Management Header 10.1 Use Of Visual Tests Prior To And General Anesthesia During Cataract Surgery CIM 35-44 10.2 Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain CIM 45-19 10.3 Inpatient Hospital Pain Rehabilitation Programs CIM 35-21 10.4 Outpatient Hospital Pain Rehabilitation Programs CIM 35-21.1 10.5 Autogenous Epidural Blood Graft CIM 45-11 10.6 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 20 Cardiovascular System Header 20. 1 Vertebral Artery Surgery CIM 35-37 20. 2 Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery CIM 35-37 20.3 Thoracic Duct Drainage (TDD) In Renal Transplants CIM 35-58 20.4 Implantation of Automatic Defibrillators CIM 35-85 20.5 Extracorporeal Immunoadsorption (ECI) Using Protein A Columns  CIM 35-90 20.6 Transmyocardial Revascularization (TMR) CIM 35-94 20.7 Percutaneous Transluminal Angioplasty (PTA)    CIM 50-32 20.8 Cardiac Pacemakers CIM 65-6 NCD Section Title CIM Section # 20.8.1 Cardiac Pacemaker Evaluation Services CIM 50-1 20.8.1.1 Transtelephonic Monitoring of Cardiac Pacemakers CIM 50-1 20.8.2 Self-Contained Pacemaker Monitors CIM 60-7 20.8.3 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 20.9 Artificial Hearts and Related Devices CIM 65-16 20.10 Cardiac Rehabilitation Programs CIM 35-25 20.11 Intraoperative Ventricular Mapping  CIM 35-75 20.12 Diagnostic Endocardial Electrical Stimulation (Pacing)    CIM 35-78 20.13 HIS Bundle Study CIM 50-3 20.14 Plethysmography CIM
(Medicare National Coverage Determinations Manual)
Intraoperative Ventricular Mapping  CIM 35-75 20.12 Diagnostic Endocardial Electrical Stimulation (Pacing)    CIM 35-78 20.13 HIS Bundle Study CIM 50-3 20.14 Plethysmography CIM 50-6 20.15 Electrocardiographic Services CIM 50-15 20.16 Cardiac Output Monitoring By Electrical Bioimpedance CIM 50-54 20.17 Noninvasive Tests of Carotid Function CIM 50-37 20.18 Carotid Body Resection/Carotid Body Denervation CIM 35-7 20.19 Ambulatory Blood Pressure Monitoring CIM 50-42 20.20 External Counterpulsation (ECP) for Severe Angina CIM 35-74 20.21 Chelation Therapy for Treatment of Atherosclerosis CIM 35-64 20.22 Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis CIM 45-20 20.23 Fabric Wrapping of Abdominal Aneurysms CIM 35-34 NCD Section Title CIM Section # 20.24 Displacement Cardiography CIM 50-50 20.25 Cardiac Catheterization Performed in Other Than a Hospital Setting CIM 35-45 20.26 Partial Ventriculectomy CIM 35-95 20.27 Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test    CIM 50-47 20.28 Therapeutic Embolization CIM 35-35 20.29 Hyperbaric Oxygen Therapy CIM 35-10 30 Complementary and Alternative Medicine Header 30.1 Biofeedback Therapy CIM 35-27 30.1.1 Biofeedback Therapy For The Treatment Of Urinary Incontinence CIM 35-27.1 30.2 Thermogenic Therapy CIM 35-6 30.3 Acupuncture CIM 35-8 30.4 Electrosleep Therapy CIM 35-18 30.5 Transcendental Meditation CIM 35-92 30.6 Intravenous Histamine Therapy CIM 35-19 30.7 Laetrile and Related Substances CIM 45-10 30.8 Cellular Therapy CIM 35-5 30.9 Transillumination Light Scanning or Diaphanography CIM 50-46 40 Endocrine System and Metabolism Header 40.1 Diabetes
(Medicare National Coverage Determinations Manual)
and Related Substances CIM 45-10 30.8 Cellular Therapy CIM 35-5 30.9 Transillumination Light Scanning or Diaphanography CIM 50-46 40 Endocrine System and Metabolism Header 40.1 Diabetes Outpatient Self-Management Training CIM 80-2 40.2 Home Blood Glucose Monitors CIM 60-11 and CIM 60-14 NCD Section Title CIM Section # 40.3 Closed-Loop Blood Glucose Control Device (CBGCD) CIM 35-70 40.4 Insulin Syringe CIM 45-3 40.5 Treatment of Obesity CIM 35-26 50 Ear, Nose and Throat (ENT) Header  50.1 Speech Generating Devices CIM 60-23 50.2 Electronic Speech Aids CIM 65-5 50.3 Cochlear Implantation CIM 65-14 50.4 Tracheostomy Speaking Valve CIM 65-165 50.5 Oxygen Treatment of Inner Ear/Carbon Therapy CIM 35-29 50.6 Tinnitus Masking CIM 35-63 50.7 Cochleostomy with Neurovascular Transplant for Menieres Disease CIM 35-50 50.8 Ultrasonic Surgery CIM 35-4 60 Emergency Medicine Reserved - no text 70 Evaluation and Management of Patients (office/hospital/home) Header 70.1 Consultations With a Beneficiarys Family and Associates CIM 35-14 70.2 Consultation Services Rendered By a Podiatrist in a Skilled Nursing Facility CIM 50-8 70.2.1 Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy) CIM 50.8.1 70.3 Physicians Office Within an Institution  Coverage of Services and Supplies Incident to a Physicians Services CIM 45-15 NCD Section Title CIM Section # 70.4 Pronouncement of Death CIM 50-19 70.5 Hospital and Skilled Nursing Facility Admission Diagnostic Procedures CIM 50-28 80 Eye Header 80.1 Hydrophilic Contact Lens for Corneal Bandage CIM 45-7 80.2 Photodynamic Therapy CIM 35-100 80.3 Photosensitive Drugs CIM 45-30 80.4 Hydrophilic Contact Lenses CIM 65-1 80.5 Scleral Shell CIM 65.3 80.6